StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Down 33.5 %
Shares of NASDAQ:ATHX opened at $0.01 on Friday. Athersys has a one year low of $0.01 and a one year high of $1.99. The company has a market capitalization of $833,206.50, a P/E ratio of 0.00 and a beta of -0.90.
About Athersys
Want More Great Investing Ideas?
Featured Stories
- Five stocks we like better than Athersys
- The 3 Best Retail Stocks to Shop for in August
- Micron Technology Stock Volatile Despite Analyst Upgrades
- The Most Important Warren Buffett Stock for Investors: His Own
- McDonald’s Stock: Balancing Value and Innovation
- 3 Fintech Stocks With Good 2021 Prospects
- MarketBeat Week in Review – 6/17 – 6/21
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.